Child vaccination scheduling study in China
Part of Immune system & allergy clinical trials.
This trial surveys caregivers of young children in China to understand how they schedule their child's vaccinations. It looks at whether children get all the vaccines they need on time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 2 months and 5 years old (59 months).
- You must be willing to give your consent to participate in a survey about your child's vaccinations.
- Your child must have complete vaccination records (received all required vaccines on time).
- You must not have any communication barriers, such as trouble speaking or hearing.
- You must be physically able to participate in the survey.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study asks caregivers in Nigeria about their child's vaccines to see if offering small rewards helps more children get vaccinated. If you care for a child under 2 years old, you may be able to share your experience.
This study asks parents about their knowledge and opinions on vaccinating their children. It aims to understand what influences vaccination decisions.
This study tests two versions of a health survey designed for children aged 5 to 16 with pneumonia, brain tumors, or immune thrombocytopenia. Children and their caregivers will fill out questionnaires to see how well the surveys measure quality of life.
This study is testing a mobile health (mHealth) program to improve childhood vaccination rates among displaced families in conflict-affected areas of Nigeria. If you are a caregiver for a young child or pregnant, living in an IDP camp, you may be able to help researchers see if a phone-based tool makes it easier to get vaccines on time.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
This trial is testing whether giving the R21 malaria vaccine to infants at different ages (starting at 2 months or 3 months) works as well as starting at 6 weeks. It will help find the best schedule to protect babies against malaria.
Hear when a new Vaccination Behavior trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.